A special thank you to EIFO and Novo Holdings for their invaluable support throughout our journey so far. Your backing has been instrumental in bringing us to this point.

Now, let’s shape the future of proteomics.

#proteomics #healthcare #partnership #LCMS #biotech

With Nordic Capital’s proven track record in healthcare and technology, we are ready to accelerate innovation, expand globally, and deliver transformative solutions for researchers and clinicians.

Together, we aim to redefine how proteomics drives efficiency, quality, and insight across healthcare and life sciences. Evosep’s mission remains set in stone, and customers can expect us to continue pushing forward the standardization of LCMS-based proteomics with impactful products and solutions.”

As our CEO, Morten Bern, shares:
“Nordic Capital has great expertise across biopharma, medtech and diagnostics, and we are thrilled to have them onboard as Evosep is moving into the next growth phase.

The session will feature a talk by Magnus Jakobsson, Director & Head of Proteomics at Acrivon Therapeutics, Inc., sharing his experience and perspectives.

Meet us all week at booth #406. We’d love to chat.

Find our full program and register www.evosep.com/hupo2025/

#proteomics #LCMS